Catherine E. Willoughby

1.5k total citations · 1 hit paper
8 papers, 665 citations indexed

About

Catherine E. Willoughby is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Catherine E. Willoughby has authored 8 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Catherine E. Willoughby's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Liver physiology and pathology (2 papers). Catherine E. Willoughby is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Liver physiology and pathology (2 papers). Catherine E. Willoughby collaborates with scholars based in Spain, United States and United Kingdom. Catherine E. Willoughby's co-authors include Josep M. Llovet, Scott L. Friedman, Tim F. Greten, Richard S. Finn, Amit G. Singal, Mathias Heikenwälder, Hashem B. El‐Serag, Laura Ogle, Helen L. Reeves and Laura Torrens and has published in prestigious journals such as Hepatology, Clinical Cancer Research and Journal of Hepatology.

In The Last Decade

Catherine E. Willoughby

8 papers receiving 658 citations

Hit Papers

Nonalcoholic steatohepatitis-related hepatocellular carci... 2023 2026 2024 2025 2023 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Willoughby Spain 7 244 233 221 189 165 8 665
Annabelle Vogt Germany 15 249 1.0× 231 1.0× 220 1.0× 197 1.0× 126 0.8× 25 741
Ruizhao Qi China 11 325 1.3× 192 0.8× 222 1.0× 114 0.6× 128 0.8× 20 706
Kornelius Schulze Germany 12 295 1.2× 391 1.7× 274 1.2× 197 1.0× 358 2.2× 23 849
Shunli Shen China 16 187 0.8× 179 0.8× 349 1.6× 101 0.5× 249 1.5× 32 689
Linjing An China 11 131 0.5× 391 1.7× 111 0.5× 229 1.2× 77 0.5× 19 607
Kenichi Taguchi Japan 16 214 0.9× 197 0.8× 235 1.1× 134 0.7× 105 0.6× 19 688
C-C. Lin Taiwan 10 107 0.4× 166 0.7× 176 0.8× 207 1.1× 101 0.6× 43 559
Deyun Feng China 16 216 0.9× 92 0.4× 376 1.7× 85 0.4× 200 1.2× 46 702
Toshiki Komeda Japan 14 367 1.5× 216 0.9× 425 1.9× 175 0.9× 194 1.2× 27 864

Countries citing papers authored by Catherine E. Willoughby

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Willoughby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Willoughby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Willoughby more than expected).

Fields of papers citing papers by Catherine E. Willoughby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Willoughby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Willoughby. The network helps show where Catherine E. Willoughby may publish in the future.

Co-authorship network of co-authors of Catherine E. Willoughby

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Willoughby. A scholar is included among the top collaborators of Catherine E. Willoughby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Willoughby. Catherine E. Willoughby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Llovet, Josep M., Catherine E. Willoughby, Amit G. Singal, et al.. (2023). Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nature Reviews Gastroenterology & Hepatology. 20(8). 487–503. 203 indexed citations breakdown →
2.
Torrens, Laura, Carla Montironi, Marc Puigvehí, et al.. (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology. 74(5). 2652–2669. 107 indexed citations
3.
Bassaganyas, Laia, Roser Pinyol, Roger Esteban-Fabró, et al.. (2020). Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma. Clinical Cancer Research. 26(23). 6350–6361. 40 indexed citations
4.
Torrens, Laura, Jordi Abril‐Fornaguera, Roser Pinyol, et al.. (2020). Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Molecular Therapy. 29(2). 680–690. 74 indexed citations
5.
Esteban-Fabró, Roger, Catherine E. Willoughby, Marta Piqué‐Gili, et al.. (2020). Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma. Journal of Hepatology. 73. S40–S40. 6 indexed citations
6.
Ogle, Laura, Stephen L. Chan, Anthony W.H. Chan, et al.. (2017). Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?. British Journal of Cancer. 118(2). 248–257. 67 indexed citations
7.
Ogle, Laura, James Orr, Catherine E. Willoughby, et al.. (2016). Imagestream detection and characterisation of circulating tumour cells – A liquid biopsy for hepatocellular carcinoma?. Journal of Hepatology. 65(2). 305–313. 99 indexed citations
8.
Cornell, Liam, Joanne M. Munck, Clara Alsinet, et al.. (2014). DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival. Clinical Cancer Research. 21(4). 925–933. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026